Latest Industry Press Releases More...

We bring you the latest pharmaceutical press releases in our pharmaceutical Industry Press Releases section to help our clients gain great exposure on industry happenings. Know about mergers, deals, technology release, and other information first hand from press conferences of industry leaders with our Global pharmaceuticals Industry Press Releases.

Dragonfly Therapeutics ("Dragonfly"), a biotechnology company that develops novel immunotherapies that take advantage of the innate immune system to treat diseases, and AbbVie (NYSE: ABBV ), An international biopharmaceutical company focused on research, today announced a collaboration in research for multiple targets designed to advance a series of novel immunotherapies…

CPhI & P-MEC India – organised by Informa Markets – is set to open its doors to more than 43,000 attendees from 120 countries and 1,500 exhibitors, as new analysis shows a massive improvement in India’s global reputation. The India-specific findings of the CPhI Annual Report highlight the significant jumps…

Excelra, a leading global Data and Analytics Company today announced a Drug Repurposing collaboration with Osaka-based Maruho – a pharmaceutical company specialising in Dermatology. Under the agreement, the Drug Repurposing Data Scientists and Therapeutic area experts at Excelra will jointly work with Maruho's research team to discover and develop novel…

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Impact Therapeutics, a biotech focused on innovative drug discovery and development in anti-cancer therapeutics, announce the signing of a strategic partnership agreement. Under the terms of this agreement, WuXi STA will become the preferred Contract Development…

The South East Asia region presents a diverse range of opportunities for multinational pharmaceutical firms. During 2019, the emerging Asian region is experiencing key progress with respect to healthcare reforms, shaping opportunities for local and foreign drugmakers. A few trends are expected to persist, including those of greater cost-containment measures…

Akcea Therapeutics, Inc., a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc., today announced the closing of the exclusive licensing agreement with Pfizer Inc. (NYSE:PFE) for AKCEA-ANGPTL3-LRx  following expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act). AKCEA-ANGPTL3-LRx is an investigational antisense…

Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye, today announced the signing of an agreement (the “Agreement”) for the acquisition of Avizorex Pharma, S.L. (“AVX…

The Transasia-Erba group today unveiled Lisa XL, India’s first six plate ELISA processor at the 15th Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine Congress (APFCB) being held in Jaipur currently. The device was formally unveiled by Prof. Praveen Sharma, Chairman, Organizing Committee, APFCB Congress, in the presence of Ravi…

MedGenome, a global leader in personalized medicine, announced the development of a proprietary genotyping array to efficiently enable large-scale genetic studies focused on South Asian populations. The South Asian Research Genotyping Array by MedGenome ("SARGAM") will be optimized for capturing the unique variants found in South Asian genomes, leveraging MedGenome's…

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company developing novel cellular therapies for unmet medical needs, today provided an update on OPC1, the Company’s oligodendrocyte progenitor cell (OPC) therapy currently being tested in a Phase I/IIa clinical trial, the SCiStar Study, for the treatment of acute spinal cord injury (SCI).…

loader